Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-site Randomised Trial of an Additional Measles Vaccine at 4 Months of Age to Reduce Child Mortality in Rural Areas of Burkina Faso and Guinea-Bissau

NCT01644721 is registered in ClinicalTrials.gov with Bandim Health Project as lead sponsor.

NCT NCT01644721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01644721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-site Randomised Trial of an Additional Measles Vaccine at 4 Months of Age to Reduce Child Mortality in Rural Areas of Burkina Faso and Guinea-Bissau
Lead sponsor
Bandim Health Project
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2012
Completion date
October 31, 2016
Enrollment
3,750 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

measles vaccine